Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    systematic_literature_reviews_whitepaper
    Demystifying the SLR: “S” stands for systematic

    A structured approach to evidence-based decision-making.

    biosimilars and oncology
    The future of oncology biosimilars

    Considerations for development through 2040.

    icons connected through network_artificail_intelligence
    Decoding AI in software as a medical device (SaMD)

    Regulatory insights and market strategies.

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    Enhancing clinical trials in obesity by integrating COAs and DHTs

    7 October 2025. Register now.

    whitepaper CNS
    Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases

    22 October 2025. Register now.

  • About ICON
    About ICON
    Company history ICON at a glance Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Medical analytics presentation preview
    Healthcare Intelligence

    Clinical Research. Evolved.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Solutions
  3. Clinical & Scientific Operations
  4. Pharmacovigilance
  5. Safety writing solutions

Safety writing solutions

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

In today’s highly regulated healthcare and pharmaceutical industries, the importance of comprehensive and accurate safety writing solutions cannot be overstated. 

Regulatory authorities worldwide demand rigorous reporting to ensure that safety risks associated with drugs and medical products are effectively monitored and managed.

ICON is a trusted partner in delivering high-quality, compliant safety documentation. With a team of skilled safety medical writers and scientists, we offer flexible, scalable solutions for clients of all sizes, from small biotechs to large pharma, ensuring cost-effective, timely, and globally compliant reporting.

We have extensive experience in the generation of aggregate safety reports and continuously monitor regulatory requirements from health authorities worldwide. We offer tailored support for smaller clients while efficiently managing high-volume report delivery and global scheduling for larger organisations. To ensure cost-effectiveness, we leverage the expertise of our Safety Medical Writers and Safety Scientists from lower-cost regions, delivering high-quality results while optimising resources.

ASR_graphic

Aggregate safety report generation

ICON has extensive experience generating aggregate safety reports (ASRs) for both developmental compounds and marketed products including:

  • Development Safety Update Report (DSUR)
  • IND annual report
  • Local country-specific clinical safety reports (such as, Final Safety Report--Mexico)
  • NDA Periodic Adverse Drug Experience Report (PADER)
  • Periodic Safety Update Report (PSUR)/Periodic Benefit-Risk Evaluation Report (PBRER)
  • Addendum to Clinical Overview (ACO)
safety writing

Wherever possible, we look to remove the complexity from ASR generation. With established procedures, a global team of highly experienced safety medical writers, and the support of a dedicated safety regulatory intelligence team, we deliver fully compliant aggregate safety reports, efficiently and cost effectively, and tailored to evolving global requirements

We offer robust, proven, and inspection-ready procedures and systems, while also being able to operate within client-established frameworks. This allows us to deliver flexible, custom-fit solutions tailored to each client’s specific needs and existing capabilities.

We also offer a modular approach to our end-to-end suite of ASR services, allowing clients to select the specific level of support needed, from management of worldwide reporting schedules through to authoring, review, publishing and/or submission of individual reports. 

Risk management planning

Our Safety Medical Writers provide expert support in the development of Risk Management Plans, as well as related educational materials and targeted follow-up questionnaires. Learn more. 

Literature search & evaluation

At ICON, we apply a structured and scientific approach to literature search, ensuring comprehensive search coverage, expert analysis, and the delivery of robust, well-authored summaries by our experienced Safety Medical Writers.

Our services include:

  • Epidemiology reviews to support clinical trial planning and risk management for marketed products
  • Safety signal detection and risk assessment
  • Labelling changes and regulatory strategy for indication expansions, prescription-to-OTC switches, and updates to contraindications, precautions, warnings, or new dosage forms/routes of administration

We deliver fully referenced, structured summaries that support regulatory discussions and help facilitate efficient submission processes with regulatory authorities.

Document quality review

Our expert Safety Medical Writers enhance the quality and compliance of safety and regulatory documents through specialised review and consultation services. We ensure accuracy, consistency, and alignment with applicable guidelines, delivering clear, precise, and submission-ready documentation. 

Our services include:

  • Editorial quality checks
  • Content verification against source materials
  • Compliance reviews with regulatory standards
  • Manual assessments of AI-generated content

Partner with ICON to simplify your safety reporting and ensure global compliance. 

Contact us to find out more about our tailored safety writing solutions.

Contact us
In this section
In this section
  • Asset Development Consulting
    • Adaptive trials
    • Dose optimisation strategies
    • Due diligence and asset valuation
    • Nonclinical and pre clinical development
    • Novel statistical methods
    • Protocol Optimisation
    • Target product profile
  • Blended Solutions
  • Cardiac Safety Solutions
  • Clinical & Scientific Operations
    • Accelerated study start-up
    • Biostatistics and programming
    • Clinical Operations
      • Clinical Monitoring
        • Remote CRA hub model
        • Risk based monitoring
      • Trial Master File services
    • Data Monitoring Committee Services
    • Clinical Supplies Management
    • COVID-19
      • COVID-19 treatment and vaccine trials
    • Clinical data science
      • CDISC Data Standardisation
    • Endpoint Adjudication Services
    • Global Logistics
      • Depot and Distribution Services
      • Global Logistics factsheets
    • Interactive Response Technology
      • Help Desk Services
    • Investigator Payments
      • Tax Management and Contracting
      • The Need for Flexibility
    • Medical Affairs
    • Medical Call Centre Services
    • Medical Writing & Publishing
    • Pharmacovigilance
      • Tailored pharmacovigilance solutions for biotech and small to mid-sized companies
      • Affiliate Level Solution
      • Ensuring patient safety
      • Risk Management & REMS Solutions
      • Safety Reporting Group
      • Safety writing solutions
    • Project and Program Management
  • Commercial Positioning
    • Health Economics and Outcomes Research
    • Market Access
    • Market Research & Analytics
    • Global Medical and Commercial Agency
    • Medical & Value Communications
      • Creative & Digital Services
        • Awards
      • Publication Management
    • Patient Reported Outcomes
  • Decentralised Clinical Trials
    • In-Home Services
  • Early Clinical
    • Accelerated Pharmaceutical Solutions
    • Bioanalytical Laboratories
    • Biometrics
    • Clinical Pharmacology
    • Clinical Research Facilities
    • Early Phase Oncology
    • Ethnic Bridging Studies
    • Medical Affairs
    • Early Phase Patient Studies
    • Early Phase Obesity Trials
    • Quality and Compliance
    • TQT studies
    • Quantitative Pharmacology and Pharmacometrics
    • Volunteer Recruitment
  • Language Services
    • Clinical and Medical Translations
    • Linguistic Validation
    • Translation Technologies
  • Laboratories
    • Bioanalytical Laboratories
      • Applications
        • Pharmacokinetics
        • Biomarkers
        • Immunogenicty
        • ADCs
      • Technologies
        • Flow Cytometry
        • LC-MS/MS
        • Ligand Binding Assays
        • qPCR
      • Isotope Laboratory
    • Central Laboratories
      • Laboratory Client Services
        • Site Support Services
      • Study Management Tools
      • Digital Pathology
      • Global Data Services
      • Logistical Tools
      • Integrated Clinical Research & Laboratory Services
      • iRIS: A Focus on Local Laboratory Results
      • Laboratory Facilities
      • Quality Assurance
      • Testing Capabilities
    • Specialty Laboratories
      • Laboratory Facilities
        • Cambridge Specialty Lab
        • Portland Specialty Lab
      • Assay Development & Validation
      • Biomarker Selection
      • Soluble Protein Assays
      • Histopathology/IHC
      • Genomics
      • Flow Cytometry
    • Biospecimen Services
    • Biotech Laboratory Solutions
  • Medical Imaging
    • Collect and hold
    • Imaging therapeutic expertise
      • Cardiovascular
      • Central Nervous System
      • MASH/MASLD & Metabolic
      • Oncology
    • Rescue studies
    • Technology platforms
  • Outcome Measures
    • Clinical Outcome Assessments
    • Digital Health Technologies
    • eCOA Technology
  • Real World Intelligence
    • Clinical Trial Tokenisation
    • Real World Evidence and Late Phase Research
      • Remote Monitoring for Late Phase
    • RWE Strategy and Analytics
  • Regulatory Affairs
    • Regulatory Project Services
    • Global Regulatory Strategy
    • CMC & Quality Services
    • Regulatory Operations
    • Global Labelling & Ad Promotion
    • Regulatory Affairs Medical Devices & IVD
    • Clinical Trial Global Regulatory
    • Clinical Diagnostics Regulatory Affairs: IVD/CDx
  • Symphony Health data
    • What we do
      • Real world data assets
      • Technologies
    • Who we serve
      • Life sciences
      • Agencies & media
      • Financial services
    • Symphony Health Conference Posters
    • Health technology and business intelligence solutions
    • Integrated Dataverse and Source Solutions
    • Optimise brand strategy and sales effectiveness
      • HealthRankings
    • Solve market access challenges
    • Understand the patient journey
    • Making Medicines More Affordable
  • Site & Patient Solutions
    • Patient Centred Services
      • Concierge Services
      • Patient Insights and Engagement
      • Patient Recruitment
    • Site & patient obesity solutions
    • Sites
      • ICON’s Elite Sites Program
      • Global Site Network
  • Strategic Solutions
    • Careers in Strategic Solutions
      • CRA careers insight webinar
      • Meet our team
        • Meet Christina Mathiasz - CRA
        • Meet Jianna Jaramillo - Sr CRA
        • Meet Param Dave - Sr CRA
        • Meet Samuel Rabanaque - Operations Manager
        • Meet Tam Le - Study Start-up Associate
    • Data-enabled FSP
    • Organisational design
    • Technology-led innovation
  • Technologies
    • AI at ICON
      • One Search
      • Cassandra
    • LabView360
    • Signet
    • ARCADES
    • FIRECREST
      • Site Portal
      • Learn
        • Training
        • Visit-by-Visit Guide
        • Medical Animation
        • Patient Education
      • Engage
        • Referral Management Console
        • Safety Letters
        • Site Question Management
        • Study News
        • Pre-Screen
        • Document Exchange and Tracking
    • ICON Digital Platform
    • OneView
    • Safety Reporting Solution
    • Evidence Platform
    • FLEX ADVANTAGE
    • Medical Imaging Technology
    • Drug Safety Reporting Solution
    • NONMEM
      • NONMEM FAQs
    • Clinical Data Studio
    • PDx-POP
    • PubsHub
      • Journals & Congresses℠
      • Knowledge Manager℠
      • PMSolution℠
    • SIMS
    • ICOMaster for eTMF
    • Prism Connect
    • SmartDraft
    • HORIZON

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media

Related information:

Webpage

Pharmacovigilance

Factsheet

Safety surveillance

Factsheet

Signet

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2025 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?